1.Unveiling the role of Pafah1b3 in liver fibrosis: A novel mechanism revealed.
Lifan LIN ; Shouzhang YANG ; Xinmiao LI ; Weizhi ZHANG ; Jianjian ZHENG
Journal of Pharmaceutical Analysis 2025;15(1):101158-101158
Liver fibrosis is a common outcome of various chronic hepatic insults, characterized by excessive extracellular matrix (ECM) deposition. The precise mechanisms, however, remain largely undefined. This study identified an elevated expression of platelet-activating factor acetylhydrolase 1B3 (Pafah1b3) in liver tissues from both carbon tetrachloride (CCl4)-treated mice and patients with cirrhosis. Deletion of Pafah1b3 significantly attenuated CCl4-induced fibrosis, hepatic stellate cell (HSC) activation, and activation of transforming growth factor-β (TGF-β) signaling. Mechanistically, PAFAH1B3 binds to mothers against decapentaplegic homolog 7 (SMAD7), disrupting SMAD7's interaction with TGF-β receptor 1 (TβR1), which subsequently decreases TβR1 ubiquitination and degradation. Pharmacological inhibition using 3-IN-P11, a specific Pafah1b3 inhibitor, conferred protective effects against CCl4-induced fibrosis in mice. Furthermore, Pafah1b3 deficiency reduced hepatic inflammation. Overall, these results establish a pivotal role for Pafah1b3 in modulating TGF-β signaling and driving HSC activation.
2.Incidence of active tuberculosis in HIV-infected individuals not receiving universal tuberculosis preventive treatment.
Ling CHEN ; Lifan ZHANG ; Leidan ZHANG ; Liyuan ZHENG ; Jia TANG ; Xiaojing SONG ; Yanling LI ; Xiaoxia LI ; Wei LV ; Ling LUO ; Fuping GUO ; Xinchao LIU ; Guiren RUAN ; Huanling WANG ; Yang HAN ; Taisheng LI ; Wei CAO
Chinese Medical Journal 2024;137(22):2761-2763
3.Nanoengineered mitochondria enable ocular mitochondrial disease therapy via the replacement of dysfunctional mitochondria.
Yi WANG ; Nahui LIU ; Lifan HU ; Jingsong YANG ; Mengmeng HAN ; Tianjiao ZHOU ; Lei XING ; Hulin JIANG
Acta Pharmaceutica Sinica B 2024;14(12):5435-5450
Leber's hereditary optic neuropathy (LHON) is an ocular mitochondrial disease that involves the impairment of mitochondrial complex I, which is an important contributor to blindness among young adults across the globe. However, the disorder has no available cures, since the approved drug idebenone for LHON in Europe relies on bypassing complex I defects rather than fixing them. Herein, PARKIN mRNA-loaded nanoparticle (mNP)-engineered mitochondria (mNP-Mito) were designed to replace dysfunctional mitochondria with the delivery of exogenous mitochondria, normalizing the function of complex I for treating LHON. The mNP-Mito facilitated the supplementation of healthy mitochondria containing functional complex I via mitochondrial transfer, along with the elimination of dysfunctional mitochondria with impaired complex I via an enhanced PARKIN-mediated mitophagy process. In a mouse model induced with a complex I inhibitor (rotenone, Rot), mNP-Mito enhanced the presence of healthy mitochondria and exhibited a sharp increase in complex I activity (76.5%) compared to the group exposed to Rot damage (29.5%), which greatly promoted the restoration of ATP generation and mitigation of ocular mitochondrial disease-related phenotypes. This study highlights the significance of nanoengineered mitochondria as a promising and feasible tool for the replacement of dysfunctional mitochondria and the repair of mitochondrial function in mitochondrial disease therapies.
4.Research progress of olfactory dysfunction in Parkinson′s disease
Wendi XU ; Tao CHEN ; Qiang YANG ; Danting ZENG ; Xi LI ; Lifan ZHONG ; Benchi CAI
Journal of Chinese Physician 2023;25(4):622-626
Parkinson′s disease (PD) is the second most common neurodegenerative disease in middle-aged and elderly people. In addition to motor symptoms, PD also has many non motor symptoms, such as dysosmia, constipation, cognitive impairment, etc. Among them, dysosmia is a common non motor symptom of early Parkinson′s disease. Research has confirmed that olfactory dysfunction (OD) can appear before the typical clinical symptoms of PD, which is of great significance to the diagnosis and treatment of diseases. However, at present, the pathogenesis of OD is still unclear, and the inspection methods have not been unified, and there is no complete cure. This article reviews the latest research progress of dysosmia in Parkinson′s disease.
5.Discovery of ARF1-targeting inhibitor demethylzeylasteral as a potential agent against breast cancer.
Jie CHANG ; Ruirui YANG ; Lifan CHEN ; Zisheng FAN ; Jingyi ZHOU ; Hao GUO ; Yinghui ZHANG ; Yadan LIU ; Guizhen ZHOU ; Keke ZHANG ; Kaixian CHEN ; Hualiang JIANG ; Mingyue ZHENG ; Sulin ZHANG
Acta Pharmaceutica Sinica B 2022;12(5):2619-2622
Image 1.
6.Clinical features and influencing factors of long-term prognosis in patients with tuberculous meningitis
Zhengrong YANG ; Lifan ZHANG ; Baotong ZHOU ; Xiaochun SHI ; Wei CAO ; Hongwei FAN ; Zhengyin LIU ; Taisheng LI ; Xiaoqing LIU
Chinese Journal of Internal Medicine 2022;61(7):764-770
Objective:To investigate the clinical features and influencing factors of long-term prognosis of tuberculous meningitis(TBM), and to provide a recommendation for treatment and early intervention of TBM.Methods:Clinical data of TBM patients were retrospectively collected at Peking Union Medical College Hospital from January 2014 to December 2021. Patients who were followed-up more than one year were divided into two groups according to modified Rankin Scale (mRS). Risk factors associated with long-term prognosis were analyze by conditional logistic stepwise regression.Results:A total of 60 subjects were enrolled including 33 (55%) males and 27 (45%) females with age 15-79 (44.5±19.8) years. There were 30 cases (50%) complicated with encephalitis, 21 cases (35%) with miliary tuberculosis. The diagnosis was microbiologically confirmed in 22 patients (36.7%), including 5 cases (22.7%, 5/22) by acid-fast staining, 8 cases (36.4%, 8/22) by Mycobacterium tuberculosis (MTB) culture, and 20 cases (90.9%, 20/22) by molecular biology. The median follow-up period was 52(43, 66 ) months in 55 cases surviving more than one year. Among them, 40 cases (72.7%) were in favorable group (mRS 0-2) and 15 cases (27.3%) were in unfavorable group (mRS 3-6) with poor prognosis. The mortality rate was 20% (11/55). Elderly ( OR=1.06, P=0.048 ) , hyponatremia( OR=0.81, P=0.020), high protein level in cerebrospinal fluid (CSF) ( OR=3.32, P=0.033), cerebral infarction( OR=10.50, P=0.040) and hydrocephalus( OR=8.51, P=0.049) were associated with poor prognosis in TBM patients. Conclusions:The mortality rate is high in patients with TBM. Molecular biology tests improves the sensitivity and shorten the diagnosis time of TBM. Elderly, hyponatremia, high protein level in CSF, cerebral infarction and hydrocephalus are independent risk factors of long-term survival in TBM patients.
7.Effect of Baicalin on the Necroptosis of Mouse Colon Cancer in Vitro
Aixia YANG ; Biao WU ; Wei HE ; Bicheng HU ; Hegui HUANG ; Lei XU ; Lifan ZHANG
Herald of Medicine 2019;38(2):167-172
Objective To investigate the effect of baicalin on CT26.WT cells of colon cancer in mice, and to discuss the cell death form. Methods CT26.WT cells were divided into four groups including of control group , routine cultured in fresh medium, the baicalin group, added with concentration of 100 μmol·L-1 baicalin, the z-VAD-fmk group, was added with final concentration of 20 μmol·L-1 z-VAD-fmk, and the combination group, added final concentration of 20 μmol·L-1 z-VADfmk,1 h before adding 100 μmol·L-1 baicalin. Then the inhibitory effect of baicalin on cell proliferation and cell viability were detected by CCK-8 method. The changes of nucleus were detected by DAPI staining, the ultrastructure of cells was observed by TEM, and the effect of baicalin on the expression of RIP3 gene and protein in cells was detected by QPCR method and Western blotting. Results Compared with control group, the differences of baicalin group and combination group had statistically significance (P<0.05) . cell death rate for control group was (10.54±0.19) % ,for baicalin group was (34.93±0.16) % ,for z- VAD group was (11.23±0.59) %, and combination group was (23.27±1.20) % (P<0.01) . Compared with the normal control group, baicalin group showed nuclear concentration and fragmentation. there was obvious nuclear fragmentation in the combination group against baicalin group. The results of electron microscopy showed that the cells of baicalin were necrotic, cell swelling, mitochondria swelling and contents leaking. Baicalin group significantly up - regulated RIP3 mRNA expression (P < 0. 01) and enhanced RIP3 protein expression (P < 0. 05) . Conclusion Baicalin induces the necrosis of ct26. WT cells, and can significantly increase the gene and protein expression of RIP3.
8.A case report of extracorporeal membrane oxygenation assisted transcatheter aortic valve replacement in a patient with severe aortic valve stenosis and advanced heart failure
Lifan YANG ; Wenzhi PAN ; Hao LAI ; Xin LI ; Cuizhen PAN ; Wei LI ; Shasha CHEN ; Qinchun JIN ; Daxin ZHOU ; Junbo GE
Chinese Journal of Cardiology 2019;47(11):913-915
9.Kinetics of serum HBsAg in chronichepatitis B patients with nucleos(t)ide analogues treatment
Mengyang ZHANG ; Susu YE ; Xiaoqing LIU ; Shaoxia XU ; Baotong ZHOU ; Xiaochun SHI ; Hong XU ; Yang HAN ; Lifan ZHANG ; Guohua DENG
Basic & Clinical Medicine 2017;37(6):817-820
Objective To summarize and analyze the dynamic change of HBsAg levels in patients with chronic Hepatitis B (CHB) after receiving nucleos(t)ide analogues (NAs) as antiviral treatment.Methods Patients who were performed quantitative Hepatitis B surface antigen(qHBsAg) from July 30, 2012 to December 30,2016 in Peking Union Medical College Hospital were retrospectively enrolled.qHBsAg, HBV DNA, HBeAg were collected and analyzed at baseline and at 192-week follow-up every 24 weeks.qHBsAg and HBeAg were assessed with chemiluminesent microparticle immuno assay(CMIA).HBV DNA was assessed with PCR and COBAS Amplicor.Results 60 patients were included.Patients in HBeAg-positive group had higher HBV DNA than that in HBeAg-negative group (P<0.05)at baseline and the two groups both were under detection limit after 48 weeks.BaselineqHBsAg in HBeAg positive-group and negative-group were (3.43±0.73) log10 IU/mL, (3.08±0.47) log10 IU/mL respectively.qHBsAg in HBeAg-positive group was higher than that in HBeAg negative-group on all follow-ups(P<0.05) except 48weeks.However on 168 weeks and 192 weeks, difference between the two groups was statistically significant(P<0.05).In HBeAg-positive group,quantitative HBeAg dropped significantly during antiviral treatment.Conclusions HBV replication can be suppressed in the process of long-term NAs treatment in CHB patients.However qHBsAg decline is not so obvious, which indicates that HBsAg cleavence is difficult,and long-term NAs therapy is still necessary.
10.Analysis of the risk factors for post-operative respiratory failure in elderly cardiac carcinoma patients
Lifan ZHANG ; Huaihong XU ; Minjie YANG ; Huibiao ZHANG
Chinese Journal of Primary Medicine and Pharmacy 2010;17(11):1496-1498
Objective To analyze the risk factors of post-operative respiratory failure in elderly cardiac carcinoma patients.Methods 28 elderly patients with respiratory failure (respiratory failure group) after the resection of cardiac carcinoma and 56 controls (control group) were studied.Preoperative respiratory function,the other complications,the site of incision,intravenous infusion,age of patients and smoking between two groups were compared by Logistic regression.Results Univariate risk factors included MVV<50% ,RV/TLC>50% ,FEV1<1.5L,PEF<70% ,DLCO<80% ,V75<70% ,the venous input,incision at chest.Multivariate logistic regression analysis identified that MVV<50% ,RV/TLC>50% ,FEV,<1.5 L,DLCO<80% were risk factors.Conclusion These results suggested that the patients with risk factors described above need more careful pre and post operative surveillance and management.

Result Analysis
Print
Save
E-mail